MDS uses SAS to improve CRO-sponsor collaboration

By Nick Taylor

- Last updated on GMT

Related tags Clinical trial Mds

MDS Pharma Services has adopted SAS Drug Development to allow for closer collaboration with sponsors and provide a centralised, integrated system for data management and analysis.

The pressure on contract research organisations (CRO) to maximise efficiency has been particularly pronounced over the past 12 months as the knock-on effects of pharma’s problems have been felt.

MDS believes the adoption of SAS will help its efficiency drive. The software provides integration and traceability of data from its initial capture through to submission and speeds its conversion into formats established by the Clinical Data Interchange Standards Consortium (CDISC).

This readies the data for electronic new drug applications (NDA) and the software can also convert it into the form requested by the Clinical Data Acquisition Standards Harmonization (CDASH) for electronic case report forms.

MDS has applied the software across its operations from preclinical through to Phase IIa. Integration also allows sponsors running SAS software immediate access to their clinical trial data, speeding the decision making process. Those without SAS software will still benefit.

Sponsors, as well as MDS, are also automatically alerted when new content becomes available. Furthermore, MDS believes the software can increase trust between CRO and sponsor by documenting the changes made to a piece of content.

When sponsor and CRO work together across the shared and managed SAS technology infrastructure, they experience a tremendous leap in data sharing and review​”, added David Handelsman, business solutions manager, life sciences research and development, at SAS.

Pharmas are increasingly entering into extensive outsourcing deals with service providers and in this environment the ability to closely monitor and collaborate on the project is desirable. By adopting the SAS software MDS believes it is equipped to prosper in this environment.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more